Skip to content

SCHEDULE 13GAccepted Feb 17, 8:31 AM ET

MapLight Therapeutics, Inc. SCHEDULE 13G

Forbion Growth Opportunities Fund III Cooperatief U.A.

Accepted (ET)

8:31 AM

Feb 17, 2026

Filed

Feb 17, 2026

Documents

1

Size

8.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.